Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02336 is a long intergenic non-protein coding RNA gene, belonging to the large class of lincRNAs which are autonomously transcribed RNA molecules longer than 200 nucleotides and do not code for protein. LincRNAs commonly regulate gene expression through mechanisms involving chromatin remodeling, modulation of nuclear architecture, RNA stabilization, and enhancer-like activity. Most lincRNAs are tissue-specific and have diverse functions, but the majority—including LINC02336—remain uncharacterized for specific biological activity. While some lincRNAs are important in disease biology (e.g., as cancer regulators or epigenetic modulators), no direct association with disease or utility as a therapeutic target has been reported for LINC02336.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2336 (LINC02336).